Research Update: Surgery Partners Inc. Outlook Raised To Positive On Equity Raise, 'B-' Rating Affirmed - S&P Global Ratings’ Credit Research

Research Update: Surgery Partners Inc. Outlook Raised To Positive On Equity Raise, 'B-' Rating Affirmed

Research Update: Surgery Partners Inc. Outlook Raised To Positive On Equity Raise, 'B-' Rating Affirmed - S&P Global Ratings’ Credit Research
Research Update: Surgery Partners Inc. Outlook Raised To Positive On Equity Raise, 'B-' Rating Affirmed
Published Dec 01, 2022
7 pages (2704 words) — Published Dec 01, 2022
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

Surgery Partners Inc. recently raised new equity through a $575 million public offering of common stock and expects to complete a $225 million private placement with its majority owner, Bain Capital, within 30 days. In addition, the company granted the underwriters an option to purchase additional shares that could raise up to $86 million. We expect the company will use about $700 million-$720 million of the proceeds to prepay debt, with the remaining cash, net of fees and expenses, going to the balance sheet. Following the debt repayment, we forecast S&P Global Ratings'-adjusted debt to EBITDA of 7.4x in 2023 and 6.8x in 2024, compared with our previous expectation of 8.3x and 7.8x in 2023 and 2024, respectively. We have

  
Brief Excerpt:

...- Surgery Partners Inc. recently raised new equity through a $575 million public offering of common stock and expects to complete a $225 million private placement with its majority owner, Bain Capital, within 30 days. In addition, the company granted the underwriters an option to purchase additional shares that could raise up to $86 million. We expect the company will use about $700 million-$720 million of the proceeds to prepay debt, with the remaining cash, net of fees and expenses, going to the balance sheet. - Following the debt repayment, we forecast S&P Global Ratings'-adjusted debt to EBITDA of 7.4x in 2023 and 6.8x in 2024, compared with our previous expectation of 8.3x and 7.8x in 2023 and 2024, respectively. - We have also raised our discretionary cash flow expectations, after capital expenditures and distribution to non-controlling interests, to about $70 million-$80 million by the end 2023, from our prior expectation of about $30 million. - We revised our outlook on Surgery...

  
Report Type:

Research Update

Ticker
Issuer
GICS
Health Care Facilities (35102020)
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: Surgery Partners Inc. Outlook Raised To Positive On Equity Raise, 'B-' Rating Affirmed" Dec 01, 2022. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Surgery-Partners-Inc-Outlook-Raised-To-Positive-On-Equity-Raise-B-Rating-Affirmed-2924104>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: Surgery Partners Inc. Outlook Raised To Positive On Equity Raise, 'B-' Rating Affirmed Dec 01, 2022. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Surgery-Partners-Inc-Outlook-Raised-To-Positive-On-Equity-Raise-B-Rating-Affirmed-2924104>
  
US$ 225.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.